Background The restenosis after coronary angioplasty is the unresolved problem even if the improvement of interventional skills and pharmacological therapies. Nitric oxide, known as endothelial derived relaxing factor EDRF , regulates the vascular tone and inhibits the proliferation of vascular smooth muscle cells and platelet adhesions and endothelium-leukocyte interactions. Nitric oxide is produced by endothelial nitric oxide synthase eNOS . We studied the significance of eNOS gene polymorphism for the prediction of restenosis after coronary angioplasty in Koreans with ischemic heart disease. Methods We analyzed the two eNOS poly-morphisms using PCR eNOS A/B polymorphism is the VNTR in intron 4 and eNOS T/G polymorphism is a missense mutation in exon 7 in 199 Korean patients who had 257 lesions undergoing percutaneous coronary angioplasty ballooning 152, stenting 105 . The angiography was repeated 6 months later to assess the relation between the rate of restenosis and types of eNOS gene polymorphism. Results We found no significant differences of restenosis rate in eNOS A B and T G polymorphism in those with balloon angioplasty or with stent restenosis rate of A A, A B, B B, respectively n 257 25% 1 4 , 26% 14 53 , 31% 62 200 p not significant , and T /T, T G, G G n 249 0% 0/3 , 36% 16 44 , 29% 58 202 p not significant Patients with A allele non BB or GG phenotype had lower restenosis rate, so we analyzed protective effect of non BB and GG phenotype on restenosis, but there was no significant statistical difference restenosis rate of non BB and GG, BB and non GG respectively 20% 15 57 , 34% 16 47 p not significant . Conclusion
A smaller rare allele A allele has four tandem 27 bp repeats and a common larger one B allele has five repeats. The first two repeats has A and the last two has G at the 19 th base of the 27 bp repeat in A allele. The first three repeats has A and the last two has G at the 19 th base of the 27 bp repeat in B allele. VNTR variable number of tandem repeats. 
